Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1093-1098

  Shimizu, Takeshi ^a   Fan, Yang ^b   Yamana, Daisuke ^c   Miura, Takuya ^c   Nanashima, Naoki ^c   Yamada, Toshiyuki ^a   Tsuchida, Shigeki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY ALKENAL; CLOFIBRATE; GLUTATHIONE TRANSFERASE A4; LIPID PEROXIDASE; LIPID PEROXIDE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENOTOXICITY; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; CLOFIBRATE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; NF-E2-RELATED FACTOR 2; PRECANCEROUS CONDITIONS; RATS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953192302     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01508.x     Document Type: Article

References (41)

1. Svoboda DJ, Azarnoff DL. Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J Cell Biol 1966, 39:442-50.
2. Corton JC, Lapinskas PJ, Gonzales FJ. Central role of PPARalpha in the mechanism of action of hepatocarcinogenic peroxisome proliferators. Mutat Res 2000, 448:139-51.
3. Rusyn I, Peters JM, Cunningham ML. Effects of DEHP in the liver: modes of action and species-specific differences. Crit Rev Toxicol 2006, 36:459-79.
4. Svoboda DJ, Azarnoff DL. Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res 1979, 39:3419-28.
5. Reddy JK, Azarnoff DL, Hignite CE. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogenesis. Nature 1980, 283:397-8.
6. Warren JR, Simmon VF, Reddy JK. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. Cancer Res 1980, 40:36-41.
7. Gupta RC, Goel SK, Earley K, Singh B, Reddy JK. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro. Carcinogenesis 1985, 6:933-6.
8. Reddy JK. Peroxisome proliferators and peroxisome proliferator-activated receptor α: biotic and xenobiotic sensing. Am J Pathol 2004, 164:2305-21.
9. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat Res 2005, 575:61-84.
10. Fielden MR, Brennan R, Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol Sci 2007, 99:90-100.
11. Rao MS, Nemali MR, Usuda N. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res 1988, 48:4919-25.
12. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985, 82:3964-8.
13. Fan Y, Shimizu T, Yamada T. Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2 related factor 2 expression during early stage of rat hepatocarcinogenesis. Cancer Sci 2008, 99:497-501.
14. Yokoyama Y, Tsuchida S, Hatayama I. Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by peroxisome proliferators in rat livers. Carcinogenesis 1992, 13:265-9.
15. Yokoyama Y, Tsuchida S, Hatayama I, Sato K. Lack of peroxisomal enzyme inducibility in rat hepatic preneoplastic lesions induced by mutagenic carcinogens: contrasted expression of glutathione S-transferase P form and enoyl CoA hydratase. Carcinogenesis 1993, 14:393-8.
16. Kudo T, Asano J, Shimizu T. Different susceptibility to peroxisome proliferator-induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes. Cancer Sci 2006, 97:703-9.
17. Esterbauer H, Cheeseman KH, Dianzani MU, Poli G, Slater TF. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochem J 1982, 208:129-40.
18. Jensson H, Guthenberg C, Alin P, Mannervik B. Rat glutathione transferase 8-8, an enzyme efficiently detoxifying 4-hydroxyalk-2-enals. FEBS Lett 1986, 203:207-9.
19. Itoh K, Chiba T, Takahashi S. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 1997, 236:313-22.
20. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009, 34:176-88.
21. Solt D, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976, 263:701-3.
22. Tsuchida S, Sato K. Rat spleen glutathione transferases. A new acidic form belonging to the Alpha class. Biochem J 1990, 266:461-5.
23. Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981, 29:577-80.
24. Satoh K, Hatayama I, Tateoka N. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 1989, 10:2107-11.
25. Itoh K, Wakabayashi N, Katoh Y. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999, 13:76-86.
26. Kasai H, Okabe Y, Nishimura S, Rao MS, Reddy JK. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 1989, 49:2603-5.
27. Rusyn I, Asakura S, Pachkowski B. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 2004, 64:1050-7.
28. Sharma R, Brown D, Awasthi S. Transfection with 4-hydroxynonenal-metabolizing glutathione S-transferase isozymes leads to phenotypic transformation and immortalization of adherent cells. Eur J Biochem 2004, 271:1690-701.
29. Patrick B, Li J, Jeyabal PV. Depletion of 4-hydroxynonenal in hGSTA4-transfected HLE B-3 cells results in profound changes in gene expression. Biochem Biophys Res Commun 2005, 334:425-32.
30. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 2004, 101:2040-50.
31. Padmanabhan B, Tong KI, Ohta T. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell 2006, 21:689-700.
32. Shibata T, Ohta T, Tong KI. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 2008, 105:13568-73.
33. Kwak MK, Wakabayashi N, Kensler TW. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat Res 2004, 555:133-48.
34. Imaida K, Fukushima S, Shirai T, Ohtani M, Nakanishi K, Ito N. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. Carcinogenesis 1983, 4:895-9.
35. Kurata Y, Fukushima S, Hasegawa R. Structure-activity relations in promotion of rat urinary bladder carcinogenesis by phenolic antioxidants. Jpn J Cancer Res 1990, 81:754-9.
36. Bomhard E. Frequency of spontaneous tumors in Wistar rats in 30-month studies. Exp Toxicol Pathol 1992, 44:381-92.
37. Haseman JK, Hailey JR, Morris RW. Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol Pathol 1998, 26:428-41.
38. van Ravenzwaay B, Tennekes H. A Wistar rat strain prone to spontaneous liver tumor development: implications for carcinogenic risk assessment. Regul Toxicol Pharmacol 2002, 36:86-95.
39. Fukuda S, Iida H. Life span and spontaneous tumor incidence of the Wistar Mishima (WM/MsNrs) rat. Exp Anim 2003, 52:173-8.
40. Mitaka T, Tsukada H. Sexual difference in the histochemical characteristics of " altered cell foci" in the liver of aged Fischer 344 rats. Jpn J Cancer Res 1987, 78:785-90.
41. Tsuda H, Asamoto M, Iwahori Y. Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver. Carcinogenesis 1996, 17:2441-8.